← Back to headlines
Deutsche Bank Maintains 'Sell' Rating on AstraZeneca (AZN)
Deutsche Bank has reiterated its 'Sell' rating on pharmaceutical giant AstraZeneca (AZN) stock. This financial assessment reflects the bank's current outlook on the company's market performance and future prospects.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Calapan drug sting seizes P73,000 worth of shabu
just now
20 people fall ill after eating 'aloy' fish in Iloilo, Philippines
just now
Back pain is not normal. RSU researchers explain how a disc herniation forms and when surgery is needed
just now
Sammi Awuku to question GMA in Parliament over vessel linked to alleged drug trafficking
13m ago